Skip to main content
    I

    INmune Bio Inc (INMB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.96
    +0.01 (+1.44%)

    Market Cap: $29.30M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    INmune Bio Inc (INMB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    INmune Bio (INMB) has a latest price of $0.96 on Nov 17, 2026, 63.1% below its 52-week high of $2.60. Its price fell 32.4% over the past 12 months. The month-end price fell 92.1% over the 5 years through Oct 2026, a compound annual decline of 39.8%.

    Price Chart

    From Feb 2019 to Oct 2026, its highest month-end close was $23.72 in Aug 2021 and its lowest $1.13 in Mar 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart INMB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INMB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 57.0%, and over 6 months it fell 31.9%. The month-end price fell 80.1% over the 3 years through Oct 2026, a compound annual decline of 41.6%.

    PeriodChange
    1 month-37.7%
    3 months-57.0%
    6 months-31.9%
    12 months-32.4%
    12 months, with dividends-32.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-80.1%-41.6%
    5 years-92.1%-39.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 196.9%, and its weakest was 2025, when it fell 66.6%.

    YearCloseChange
    2026 through Oct 2026$1.45-7.1%
    2025$1.56-66.6%
    2024$4.67-58.5%
    2023$11.26+77.6%
    2022$6.34-37.8%
    2021$10.20-40.8%
    2020$17.22+196.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 43.5% below its 50-day average of $1.70 and 40.2% below its 200-day average of $1.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.96
    52-week high$2.60-63.1%
    52-week low$0.89+7.5%
    50-day average$1.70-43.5%
    200-day average$1.61-40.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.2%.

    MeasureValue
    1-year beta2.57
    Largest fall, 1 year-62.3%
    Largest fall, 3 years-93.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About INMB

    What is INMB's 1-year price change?

    INmune Bio's price fell 32.4% over the past 12 months. With dividends included, the 12-month total return was -32.4%.

    What is INMB's 5-year price change?

    INmune Bio's month-end price fell 92.1% over the 5 years through Oct 2026, a compound annual decline of 39.8%. These figures leave out dividends.

    What is INMB's 52-week high and low?

    INmune Bio's 52-week high is $2.60 and its 52-week low is $0.89. Its latest price of $0.96 on Nov 17, 2026 is 63.1% below the high.

    What is INMB's beta?

    INmune Bio's 1-year beta against the S&P 500 is 2.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 62.3%.

    Is the INMB chart free?

    Yes. Advanced Charting for INMB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.